Symbols

MITO(Delisted)

Stealth Bio·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About MITO

Stealth Biotherapeutics Corp

mitochondrial dysfunction biotech company

Industry

Established Date

04/03/2006

Listing Date

02/15/2019

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.stealthbt.com

Security Type

Depository Receipts (Ordinary Shares)

Office address

One Nexus way, Camana Bay , Grand Cayman , KY1-9005 Cayman Islands

Business

Provide clinical-stage biotechnology services.

Introduction

Stealth BioTherapeutics Corp, an exempted limited liability company incorporated under the laws of the Cayman Islands on 3 April 2006. The company is a clinical-stage biotechnology company headquartered in the United States, focusing on exploring, developing and commercializing new first-in-class therapies for diseases related to mitochondrial dysfunction.

Company Financials

EPS

MITO has released its 2021 Q4 earnings. EPS was reported at -0.03, versus the expected 0, missing expectations. The chart below visualizes how MITO has performed over recent quarters, highlighting trends in earnings surprises.